Metabolic Effects of Two Different Doses of Venlafaxine Therapy on Rats
References
- 1. Engl TJ, Laimer MS, et al. Metabolic side effects of antipsychotic medication. International Journal of Clinical Practice, 2007;61:1356–1370.
- 2. Crandall JP, Knowler WC, Kahn SK, et al. The prevention of type 2 diabetes. Nature Reviews Endocrinology, 2008;4:382-393.
- 3. McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH - The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms, Expert Opinion on Drug Safety, 2006;5:157-168.
- 4. Ferguson JM. SSRI Antidepressant Medications: Adverse Effects and Tolerability, Prim Care Companion. J Clin Psychiatry, 2001;3:22–27.
- 5. Masand PS, Gupta S. Long-Term side Effects of Newer-Generation Antidepressants: SSRIS, Venlafaxine, Nefazodone, Bupropion, and Mirtazapine. Annals of Clinical Psychiatry, 2002;14:175-182.
- 6. Harvey AT, Rudolph RL, Preskorn SH. Evidence of the Dual Mechanisms of Action of Venlafaxine, Arch Gen Psychiatry, 2000;57:503-509.
- 7. Kraus T, Haack M, Schuld A, Hinze-Selch D, Koethe D, Pollmächer T.
- 8. Body Weight, the Tumor Necrosis Factor System, and Leptin Production during Treatment with Mirtazapine or Venlafaxine. Pharmacopsychiatry, 2002;35:220-225.
- 9. Hummel J, Westphal S, Weber-Hamann B, Gilles M, et al. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial. The Journal of Clinical Psychiatry, 2011;72:885-891.
- 10. Khanam R, Najfi H, Akhtar M, Vohora D. Evaluation of venlafaxine on glucose homeostasis and oxidative stress in diabetic mice. Hum Exp Toxicol, 2012;31:1244-50.
- 11. Rosen ED, Sarraf P, Troy AE, et al. PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro, Molecular Cell, 1999;4:611–617.
- 12. Wasan KM, Looije NA. Emerging Pharmacological Approaches to the Treatment of Obesity, J Pharm Pharmaceut Sci, 2005;8:259-271.
- 13. Li AC, Brown KK, Silvestre MJ, et al. Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice, J Clin Invest, 2000;106:523–531.
DOI: https://doi.org/10.1515/amma-2015-0049 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Language: English
Page range: 196 - 199
Submitted on: Dec 9, 2014
Accepted on: Jun 4, 2015
Published on: Nov 7, 2015
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2015 Imre Annamária, Kolcsár Melinda, Groşan Alexandra, M Imre, Dogaru Maria Titica, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.